- Previous Close
14.33 - Open
14.39 - Bid 14.94 x --
- Ask 14.95 x --
- Day's Range
14.39 - 15.00 - 52 Week Range
9.29 - 23.50 - Volume
18,730 - Avg. Volume
68,203 - Market Cap (intraday)
298.978M - Beta (5Y Monthly) 0.30
- PE Ratio (TTM)
1,495.00 - EPS (TTM)
0.01 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Veerhealth Care Limited engages in manufacturing, marketing, and trading of ayurvedic medicines in India. The company offers skincare products, such as creams, lip balms, moisturizing lotions, face packs, rosewater, and scrubs; body care products, including bodywash, bath salts, facewash, handwash, and soaps; hair oils, shampoos, and conditioners; candles and body mist fragrances; pain relief oils, tablets, syrups, and sanitizers; toothpastes; body and beard care products; gifting products; and accessories. It also provides plastic bottles for use in various industries comprising food, cosmetics, household cleaning, pharmaceuticals, and others. The company also sells its products online. It exports its products. In addition, it manufactures and sells anesthesia delivery equipment, air compressors, and ambulances for operating room, critical care, life support, imaging, and mobile healthcare sectors. The company was formerly known as Niyati Industries Limited and changed its name to Veerhealth Care Limited in September 2013. Veerhealth Care Limited was incorporated in 1992 and is headquartered in Mumbai, India.
veerhealthcare.net29
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: VEERHEALTH.BO
View MorePerformance Overview: VEERHEALTH.BO
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VEERHEALTH.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VEERHEALTH.BO
View MoreValuation Measures
Market Cap
286.58M
Enterprise Value
278.62M
Trailing P/E
1.43k
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.02
Price/Book (mrq)
1.29
Enterprise Value/Revenue
2.00
Enterprise Value/EBITDA
15.57
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.12%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
149.81M
Net Income Avi to Common (ttm)
-177k
Diluted EPS (ttm)
0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
7.96M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--